Skip to main content

Table 5 Univariate and multivariate analysis of overall survival of stage II CRC patients

From: Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer

Risk factors

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age (> / ≤ 68, years)

2.639 (1.238–5.622)

0.012*

2.392 (1.113–5.140)

0.025*

Sex (female/male)

0.947 (0.472–1.896)

0.877

  

BMI (> / ≤ 23.4 kg/m2)

0.418 (0.202–0.868)

0.019*

0.413 (0.197–0.864)

0.019*

Hypertension (yes/no)

0.980 (0.659–1.459)

0.922

  

Tumor site (colon/ rectum)

1.439 (0.719–2.882)

0.304

  

Vessel invasion (yes/no)

1.728 (0.235–12.712)

0.591

  

Adjuvant therapy (yes/no)

1.058 (0.144–7.798)

0.956

  

Smoking (yes/no)

1.081 (0.556–2.099)

0.819

  

Drinking (yes/no)

1.442 (0.728–2.857)

0.293

  

Family history (yes/no)

2.064 (0.632–6.746)

0.230

  

CHD (yes/no)

1.503 (0.526–4.294)

0.447

  

Overall complications (yes/no)

1.642 (0.849–3.175)

0.141

  

Major complications (yes/no)

3.381 (1.025–11.149)

0.045*

3.461 (1.025–11.686)

0.046*

  1. Note: *P-value < 0.05
  2. Abbreviations: CRC Colorectal cancer, HR Hazard ratio, CI Confidence interval, BMI Body mass index, CHD Coronary heart disease, TNM Tumor nodes metastasis